Abstract
Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have